Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 14 of 257 found articles
 
 
  93MO Optimal 18F-FDG PET/CT (FDG-PET) cut-off for pathological complete response (pCR) prediction in HER2-positive [HER2+] early breast cancer (EBC) patients (pts) treated with neoadjuvant trastuzumab (T) and pertuzumab (P) in PHERGain trial
 
 
Title: 93MO Optimal 18F-FDG PET/CT (FDG-PET) cut-off for pathological complete response (pCR) prediction in HER2-positive [HER2+] early breast cancer (EBC) patients (pts) treated with neoadjuvant trastuzumab (T) and pertuzumab (P) in PHERGain trial
Author: Gebhart, G.
Keyaerts, M.
Guiot, T.
Flamen, P.
Ruiz Borrego, M.
Stradella, A.
Bermejo De Las Heras, B.
Escriva de Romani, S.
Calvo-Martinez, L.
Ribelles Entrena, N.
Martinez, N.
Albacar Miro, C.R.
Colleoni, M.A.
Atienza de Frutos, M.
Sampayo-Cordero, M.
Cortés, J.
Perez Garcia, J.M.
Llombart Cussac, A.
Appeared in: Annals of oncology
Paging: Volume 33 () nr. S3 pages S166
Year: 2022
Contents:
Publisher: European Society for Medical Oncology
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 14 of 257 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands